UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q/A
Amendment No. 1
Quarterly Report Under Section 13 or 15(d) of
The Securities Exchange Act of 1934
For quarter ended: June 30, 2002 Commission File No. 0-11178
-------
UTAH MEDICAL PRODUCTS, INC.
---------------------------
(Exact name of Registrant as specified in its charter)
UTAH 87-0342734
------------------------------- ------------------
(State or other jurisdiction of (I.R.S. Employer
incorporation or organization) Identification No.)
7043 South 300 West
Midvale, Utah 84047
---------------------
Address of principal executive offices
Registrant's telephone number: (801) 566-1200
--------------
Indicate by check mark whether the registrant (1) has filed all reports
required to be filed by Sections 13 or 15(d) of the Securities Exchange Act of
1934 during the preceding 12 months (or for such shorter period that the
registrant was required to file such reports) and; (2) has been subject to such
filing requirements for the past 90 days. Yes X No
--- --
The number of shares outstanding of the registrant's common stock as of
August 13, 2002: 4,905,000
---------
PART II - OTHER INFORMATION
Item 4. Submission of Matters to a Vote of Security Holders
On May 10, 2002 at the annual meeting, shareholders of the Company approved
the following matter submitted to them for consideration:
Elected Stephen W. Bennett and Ernst G. Hoyer as directors of the Company.
Stephen W. Bennett: For 4,612,140
Ernst G. Hoyer: For 4,612,140
SIGNATURES
Pursuant to the requirements of the Securities Exchanges Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
UTAH MEDICAL PRODUCTS, INC.
REGISTRANT
Date: 8/14/02 By: /s/ Kevin L. Cornwell
-------------- ------------------------------
Kevin L. Cornwell
CEO